LUIS
ORTEGA MEDINA
Profesor asociado de Ciencias de la Salud
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (22)
2023
2021
-
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin
Molecular Oncology, Vol. 15, Núm. 12, pp. 3691-3705
-
Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma
Annals of Diagnostic Pathology, Vol. 53
2020
-
The clinical significance of PIWIL3 and PIWIL4 expression in pancreatic cancer
Journal of Clinical Medicine, Vol. 9, Núm. 5
2019
-
The prognosis value of PIWIL1 and PIWIL2 expression in pancreatic cancer
Journal of Clinical Medicine, Vol. 8, Núm. 9
2018
-
Prognostic factors in adenocarcinoma of the ampulla of Vater
Revista Espanola de Patologia, Vol. 51, Núm. 4, pp. 210-215
2009
-
Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis
Cardiovascular Research, Vol. 81, Núm. 1, pp. 216-225
2008
-
Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: A novel model of atherosclerosis associated with chronic inflammation
Arthritis and Rheumatism, Vol. 58, Núm. 9, pp. 2723-2734
-
Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis
British Journal of Pharmacology, Vol. 154, Núm. 4, pp. 843-851
-
Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis
Kidney International
2007
-
Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis
Journal of Pharmacology and Experimental Therapeutics, Vol. 320, Núm. 1, pp. 108-116
2006
-
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: Potential implications for plaque stabilization
Journal of Cardiovascular Pharmacology, Vol. 47, Núm. 1, pp. 60-69
-
Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: Modulation by atorvastatin
Stroke, Vol. 37, Núm. 8, pp. 2044-2053
-
Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: Regulation by nuclear factor-κB
Atherosclerosis, Vol. 187, Núm. 1, pp. 139-149
-
Parthenolide modulates the NF-κB-mediated inflammatory responses in experimental atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 26, Núm. 8, pp. 1864-1870
2005
-
Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month
Stroke, Vol. 36, Núm. 8, pp. 1796-1800
2004
2003
-
Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis
Stroke, Vol. 34, Núm. 7, pp. 1783-1789
-
Simvastatin reduces NF-κB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet
Cardiovascular Research, Vol. 57, Núm. 1, pp. 168-177
2001
-
Atorvastatin reduces Fas and Fas ligand expression in a rabbit experimental model of atherosclerosis
Investigacion Cardiovascular, Vol. 4, Núm. 1, pp. 15-27